Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DATE Trial: 4 vs. 7 Days of Antibiotics for Early VAP
NCT05545735Phase 4Terminated
- Sponsor
- University of Miami
- Start
- May 2023
- Primary completion
- Feb 2025
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in ventilator-associated pneumonia (VAP) (2 arms), sponsored by University of Miami. Primary endpoints: Number of Participants With Reoccurring VAP up to 21 days and Antibiotic Free Days up to 30 days. Started May 2023; status: terminated.
02
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT05545735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05545735.